T. Rowe Price Associates’s Senti Biosciences SNTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-314,712
| Closed | -$1.34M | – | 2926 |
|
|
2023
Q3 | $1.34M | Sell |
314,712
-24,621
| -7% | -$105K | ﹤0.01% | 1654 |
|
|
2023
Q2 | $2.12M | Sell |
339,333
-7,454
| -2% | -$46.5K | ﹤0.01% | 1451 |
|
|
2023
Q1 | $4.09M | Sell |
346,787
-8,615
| -2% | -$102K | ﹤0.01% | 1232 |
|
|
2022
Q4 | $5.01M | Sell |
355,402
-46,146
| -11% | -$651K | ﹤0.01% | 1187 |
|
|
2022
Q3 | $8.71M | Buy |
401,548
+42,589
| +12% | +$924K | ﹤0.01% | 1088 |
|
|
2022
Q2 | $7M | Buy |
358,959
+348,892
| +3,466% | +$6.8M | ﹤0.01% | 1376 |
|
|
2022
Q1 | $994K | Hold |
10,067
| – | – | ﹤0.01% | 2006 |
|
|
2021
Q4 | $993K | Sell |
10,067
-289,933
| -97% | -$28.6M | ﹤0.01% | 2041 |
|
|
2021
Q3 | $29.8M | Hold |
300,000
| – | – | ﹤0.01% | 1183 |
|
|
2021
Q2 | $29.8M | Buy |
+300,000
| New | +$29.8M | ﹤0.01% | 1201 |
|